BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21956541)

  • 1. Reproductive factors and Parkinson's disease: a multicenter case-control study.
    Nicoletti A; Nicoletti G; Arabia G; Annesi G; De Mari M; Lamberti P; Grasso L; Marconi R; Epifanio A; Morgante L; Cozzolino A; Barone P; Quattrone A; Zappia M
    Mov Disord; 2011 Dec; 26(14):2563-6. PubMed ID: 21956541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case control study of women with Parkinson's disease and their fertility characteristics.
    Yadav R; Shukla G; Goyal V; Singh S; Behari M
    J Neurol Sci; 2012 Aug; 319(1-2):135-8. PubMed ID: 22647587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voluptuary habits and clinical subtypes of Parkinson's disease: the FRAGAMP case-control study.
    Nicoletti A; Pugliese P; Nicoletti G; Arabia G; Annesi G; Mari MD; Lamberti P; Grasso L; Marconi R; Epifanio A; Morgante L; Cozzolino A; Barone P; Torchia G; Quattrone A; Zappia M
    Mov Disord; 2010 Oct; 25(14):2387-94. PubMed ID: 20669181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive life milestones in women with Parkinson's disease.
    Martignoni E; Nappi RE; Citterio A; Calandrella D; Zangaglia R; Mancini F; Corengia E; Riboldazzi G; Polatti F; Nappi G
    Funct Neurol; 2003; 18(4):211-7. PubMed ID: 15055746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age at menopause predicts age at onset of Parkinson's disease.
    Ragonese P; D'Amelio M; Callari G; Salemi G; Morgante L; Savettieri G
    Mov Disord; 2006 Dec; 21(12):2211-4. PubMed ID: 17029261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen therapy and risk of breast cancer in postmenopausal women: a case-control study and results of a multivariate analysis.
    Lumachi F; Frigo AC; Basso U; Tombolan V; Ermani M
    Menopause; 2010; 17(3):524-8. PubMed ID: 20130492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease and reproductive life events.
    Martignoni E; Nappi RE; Citterio A; Calandrella D; Corengia E; Fignon A; Zangaglia R; Riboldazzi G; Pacchetti C; Nappi G
    Neurol Sci; 2002 Sep; 23 Suppl 2():S85-6. PubMed ID: 12548356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to estrogen and women's risk for Parkinson's disease: a prospective cohort study in Denmark.
    Rugbjerg K; Christensen J; Tjønneland A; Olsen JH
    Parkinsonism Relat Disord; 2013 Apr; 19(4):457-60. PubMed ID: 23402992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
    Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
    Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
    Cooper GS; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS
    Arthritis Rheum; 2002 Jul; 46(7):1830-9. PubMed ID: 12124867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogens and the risk of complex regional pain syndrome (CRPS).
    de Mos M; Huygen FJ; Stricker BH; Dieleman JP; Sturkenboom MC
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):44-52. PubMed ID: 19111016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study.
    Doran MF; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2004 Feb; 31(2):207-13. PubMed ID: 14760786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
    Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
    Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive factors and clinical features of Parkinson's disease.
    Cereda E; Barichella M; Cassani E; Caccialanza R; Pezzoli G
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1094-9. PubMed ID: 23931933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal estrogen use affects risk for Parkinson disease.
    Currie LJ; Harrison MB; Trugman JM; Bennett JP; Wooten GF
    Arch Neurol; 2004 Jun; 61(6):886-8. PubMed ID: 15210525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk.
    Yu MW; Chang HC; Chang SC; Liaw YF; Lin SM; Liu CJ; Lee SD; Lin CL; Chen PJ; Lin SC; Chen CJ
    Hepatology; 2003 Dec; 38(6):1393-400. PubMed ID: 14647050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive factors and Parkinson's disease risk in Danish women.
    Greene N; Lassen CF; Rugbjerg K; Ritz B
    Eur J Neurol; 2014 Sep; 21(9):1168-77, e68. PubMed ID: 24750445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Parkinson disease in women: effect of reproductive characteristics.
    Ragonese P; D'Amelio M; Salemi G; Aridon P; Gammino M; Epifanio A; Morgante L; Savettieri G
    Neurology; 2004 Jun; 62(11):2010-4. PubMed ID: 15184606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive use and risk of colorectal cancer.
    Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
    Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the canadian national enhanced cancer surveillance system.
    Frise S; Kreiger N; Gallinger S; Tomlinson G; Cotterchio M
    Ann Epidemiol; 2006 Dec; 16(12):908-16. PubMed ID: 16843679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.